Collaboration and Other Revenue — Revenue
Products & Services · RevenueEli Lilly Collaboration and Other Revenue — Revenue decreased by 21.9% to $991.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 34.2%, from $1.51B to $991.70M. Over 4 years (FY 2021 to FY 2025), Collaboration and Other Revenue — Revenue shows an upward trend with a 15.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful monetization of intellectual property or expanded partnership activity, while a decrease may indicate fewer active collaborations or expiring licensing agreements.
Detailed definition
This metric represents revenue generated through strategic partnerships, licensing agreements, and other non-core produc...
Peer comparison
Peers in the pharmaceutical industry often report this under 'Other Revenue' or 'Licensing and Collaboration Revenue,' which varies significantly based on the company's reliance on external R&D partnerships.
lly_segment_collaborationand_other_revenue_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $669.60M | $583.80M | $621.50M | $677.10M | $617.10M | $822.40M | $962.00M | $721.80M | $1.33B | $2.19B | $1.06B | $971.50M | $947.90M | $867.50M | $1.51B | $1.13B | $831.70M | $1.27B | $991.70M |
| QoQ Change | — | -12.8% | +6.5% | +8.9% | -8.9% | +33.3% | +17.0% | -25.0% | +84.6% | +64.6% | -51.5% | -8.7% | -2.4% | -8.5% | +73.8% | -25.2% | -26.2% | +52.7% | -21.9% |
| YoY Change | — | — | — | — | -7.8% | +40.9% | +54.8% | +6.6% | +115.9% | +166.6% | +10.6% | +34.6% | -28.9% | -60.4% | +41.8% | +16.0% | -12.3% | +46.4% | -34.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's collaboration and other revenue — revenue?
- Eli Lilly (LLY) reported collaboration and other revenue — revenue of $991.70M in Q4 2025.
- How has Eli Lilly's collaboration and other revenue — revenue changed year-over-year?
- Eli Lilly's collaboration and other revenue — revenue decreased by 34.2% year-over-year, from $1.51B to $991.70M.
- What is the long-term trend for Eli Lilly's collaboration and other revenue — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's collaboration and other revenue — revenue has grown at a 15.6% compound annual growth rate (CAGR), from $2.36B to $4.22B.
- What does collaboration and other revenue — revenue mean?
- Revenue earned from strategic partnerships, licensing deals, and royalty agreements rather than direct product sales.